Walleye Capital LLC Bio N Tech Se Transaction History
Walleye Capital LLC
- $38.9 Billion
- Q4 2024
A detailed history of Walleye Capital LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Walleye Capital LLC holds 42,100 shares of BNTX stock, worth $4.75 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
42,100
Previous 90,200
53.33%
Holding current value
$4.75 Million
Previous $10.7 Million
55.22%
% of portfolio
0.01%
Previous 0.02%
Shares
5 transactions
Others Institutions Holding BNTX
# of Institutions
363Shares Held
39.6MCall Options Held
3.01MPut Options Held
2.01M-
Baillie Gifford & CO8.22MShares$928 Million0.74% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$498 Million2.03% of portfolio
-
Primecap Management CO Pasadena, CA4.3MShares$485 Million0.39% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$214 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$204 Million1.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $27.4B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...